Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. (Q33823950)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

circulatory system

1 reference

based on heuristic

inferred from title

Christopher Griffiths

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

K Reich

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

R G Langley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M Lebwohl

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

P Szapary

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

C Guzzo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

N Yeilding

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

S Li

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M-C Hsu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

164

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

862-872

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Pathogenesis and clinical features of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The psychosocial and occupational impact of chronic skin disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The psychosocial burden of psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Epidemiology of psoriatic arthritis in the population of the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Heart disease in psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The risk of stroke in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The risk of mortality in patients with psoriasis: results from a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Pathogenic mechanisms shared between psoriasis and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2011.10257.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33823950&oldid=1951446474"